Baek Gyeongran Does Not Disclose Stock Trading Records... Opposition Party "Accuses"

Baek Kyung-ran, Commissioner of the Korea Disease Control and Prevention Agency

[Asia Economy Reporter Choi Dae-yeol] Baek Kyung-ran, Commissioner of the Korea Disease Control and Prevention Agency, did not disclose the stock transaction details requested by the opposition party.

According to the National Assembly Health and Welfare Committee on the 28th, Commissioner Baek submitted stock-related documents to the committee that day but did not provide the transaction details requested by the Democratic Party of Korea. Earlier, during the comprehensive audit of the Disease Control Agency on the 20th, the committee had resolved to file a complaint against Commissioner Baek if she did not submit the stock-related documents by that afternoon.

Commissioner Baek submitted stock-related documents that included details of the sale of SK Biopharm, Syntekabio, Bodytech Med, and Alteogen. These were contents already submitted to the National Assembly. Democratic Party members have been demanding the submission of a full 10-year transaction history to understand the entire stock trading status.

It was reported that Commissioner Baek went to the National Assembly that day to explain her position and met with Health and Welfare Committee Chairperson Jung Chun-sook and opposition party floor leader Kang Hoon-sik. In the documents, Commissioner Baek explained, "After my appointment as commissioner, I judged that SK Bioscience might have a work-related connection and sold all shares," and "During the review by the Ministry of Personnel Management, the standing committee raised concerns about holding bio stocks, so I also sold all shares of four bio-related stocks."

The Democratic Party reportedly decided to proceed with filing a complaint, stating that there was no difference from the previously submitted documents.

This content was produced with the assistance of AI translation services.